Cases 31 - 40 of 237
Amicus Therapeutics US, LLC et al v. Aurobindo Pharma Ltd. et al
as 1:2022cv01467
Plaintiff:
Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Alcon Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2022cv01391
Plaintiff:
Alcon Inc. and Alcon Laboratories, Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited et al
as 1:2022cv01387
Plaintiff:
ACADIA Pharmaceuticals Inc.
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al
as 1:2022cv01270
Plaintiff:
Bial - Portela & CA S.A., Bial - Holding, S.A. and Sunovion Pharmaceuticals Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Array BioPharma, Inc. v. Eugia Pharma Specialities Limited et al
as 1:2022cv01236
Plaintiff:
Array BioPharma, Inc.
Defendant:
Eugia Pharma Specialities Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eli Lilly and Company et al v. Aurobindo Pharma Limited et al
as 1:2022cv01114
Plaintiff:
Eli Lilly & Company, Incyte Corporation, Incyte Holdings Corporation and others
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al
as 1:2022cv00971
Plaintiff:
Covis Pharma GmbH, AMAG Pharma USA, Inc. and AMAG Pharmaceuticals, Inc.
Defendant:
Eugia Pharma Specialties Ltd., Aurobindo Pharma, Ltd., Aurobindo Pharma U.S.A., Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
EISAI CO., LTD. et al v. AUROBINDO PHARMA LTD. et al
as 1:2022cv03610
Plaintiff:
EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
EISAI CO., LTD. et al v. AUROBINDO PHARMA LTD. et al
as 1:2022cv03610
Plaintiff:
EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
EISAI CO., LTD. et al v. AUROBINDO PHARMA LTD. et al
as 3:2022cv03610
Plaintiff:
EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
